Key facts
- Notable investors include Jiangsu Sukong Venture Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhongke Zhixin
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongke Zhixin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongke Zhixin
Manufacturer of clinical-grade biomedical components intended for therapeutic and cosmetic applications. The company offers proprietary formulation technologies, multi-category regulatory certifications, and integrated production systems for surgical, ophthalmic, and dermatological use, serving healthcare institutions and cosmetic clinics to access compliant, scalable, and functionally diverse solutions for patient care and aesthetic enhancement across a broad clinical spectrum.
- Sector
- Healthcare
- HQ
- Changzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Zhongke Zhixin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongke Zhixin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongke Zhixin in its N-PORT filings yet. We sweep new filings monthly.